Profile
Natalie Weigand was the Chief Executive Officer at PharmaSGP Holding SE from 2017 to 2025.
Prior to that, she served as the Managing Director at PharmaSGP GmbH from 2015 to 2020.
She also worked at Johnson & Johnson GmbH & Co. Wohnungsvermietung KG as a Manager-Brand & Marketing.
Ms. Weigand graduated from The National Film & Television School in 2012 with a graduate degree and from CBS Cologne Business School GmbH in 2004 with an undergraduate degree.
Former positions of Natalie Weigand
| Companies | Position | End |
|---|---|---|
| PHARMASGP HOLDING SE | Chief Executive Officer | 01/01/2025 |
PharmaSGP GmbH
PharmaSGP GmbH Miscellaneous Commercial ServicesCommercial Services Engages in developing and supplies therapies and pharmaceutical products | Chief Executive Officer | 01/05/2020 |
Johnson & Johnson GmbH & Co. Wohnungsvermietung KG
Johnson & Johnson GmbH & Co. Wohnungsvermietung KG Financial ConglomeratesFinance Provides financial services | Sales & Marketing | - |
Education of Natalie Weigand
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
The National Film & Television School
The National Film & Television School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CBS Cologne Business School GmbH
CBS Cologne Business School GmbH Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaSGP GmbH
PharmaSGP GmbH Miscellaneous Commercial ServicesCommercial Services Engages in developing and supplies therapies and pharmaceutical products | Commercial Services |
Johnson & Johnson GmbH & Co. Wohnungsvermietung KG
Johnson & Johnson GmbH & Co. Wohnungsvermietung KG Financial ConglomeratesFinance Provides financial services | Finance |
PharmaSGP Holding SE
PharmaSGP Holding SE Pharmaceuticals: MajorHealth Technology Develops non-prescription drugs and other health products | Health Technology |
- Stock Market
- Insiders
- Natalie Weigand
















